argenx SE (ARGX)
374.63
-7.92
(-2.07%)
USD |
NASDAQ |
May 10, 16:00
375.08
+0.45
(+0.12%)
After-Hours: 20:00
argenx Revenue (Quarterly): 406.84M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 406.84M |
| September 30, 2023 | 329.79M |
| June 30, 2023 | 270.55M |
| March 31, 2023 | 219.14M |
| December 31, 2022 | 174.16M |
| September 30, 2022 | 137.98M |
| June 30, 2022 | 75.19M |
| March 31, 2022 | 23.41M |
| December 31, 2021 | 26.02M |
| September 30, 2021 | 0.857M |
| June 30, 2021 | 312.24M |
| March 31, 2021 | 158.16M |
| December 31, 2019 | 21.28M |
| September 30, 2019 | 7.686M |
| June 30, 2019 | 8.559M |
| March 31, 2019 | 40.94M |
| December 31, 2018 | 1.422M |
| September 30, 2018 | 2.444M |
| June 30, 2018 | 13.84M |
| March 31, 2018 | 6.867M |
| Date | Value |
|---|---|
| December 31, 2017 | 10.32M |
| September 30, 2017 | 7.693M |
| June 30, 2017 | 18.56M |
| March 31, 2017 | 7.116M |
| December 31, 2016 | 3.677M |
| September 30, 2016 | 5.505M |
| June 30, 2016 | 3.780M |
| March 31, 2016 | 2.511M |
| December 31, 2015 | 1.889M |
| September 30, 2015 | 2.567M |
| June 30, 2015 | 1.727M |
| March 31, 2015 | 1.310M |
| December 31, 2014 | 1.781M |
| September 30, 2014 | 2.009M |
| June 30, 2014 | 0.3087M |
| March 31, 2014 | 0.469M |
| December 31, 2013 | 0.9344M |
| September 30, 2013 | 1.672M |
| June 30, 2013 | 0.5306M |
| March 31, 2013 | 0.5596M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.857M
Minimum
Sep 2021
406.84M
Maximum
Dec 2023
144.79M
Average
137.98M
Median
Sep 2022
Revenue (Quarterly) Benchmarks
| NuCana PLC | -- |
| Amarin Corp PLC | 56.52M |
| Koninklijke Philips NV | 4.495B |
| Biodexa Pharmaceuticals Plc | -- |
| TC BioPharm (Holdings) PLC | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -99.17M |
| Total Expenses (Quarterly) | 543.67M |
| EPS Diluted (Quarterly) | -1.69 |
| Enterprise Value | 19.08B |
| Gross Profit Margin (Quarterly) | 90.30% |
| Profit Margin (Quarterly) | -24.38% |
| Earnings Yield | -1.37% |
| Normalized Earnings Yield | -1.464 |